Rice Hall James & Associates, LLC Myriad Genetics Inc Transaction History

Rice Hall James & Associates, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $3.44 Million - $10.4 Million	-351,837 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$20.93 - $35.1 $10.2 Million - $17.1 Million	-485,811 Reduced 58.0%	351,837 $9.58 Million
Q3 2019 Oct 30, 2019	SELL	$22.08 - $47.08 $347,340 - $740,615	-15,731 Reduced 1.84%	837,648 $24 Million
Q2 2019 Aug 01, 2019	SELL	$22.67 - $35.0 $1.17 Million - $1.8 Million	-51,534 Reduced 5.69%	853,379 $23.7 Million
Q1 2019 May 01, 2019	BUY	$26.93 - $34.7 $2.81 Million - $3.62 Million	104,360 Added 13.04%	904,913 $30 Million
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $21.8 Million - $36.5 Million	800,553 New	800,553 $23.3 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.